Psoriasis
Longitudinal, multi-source, curated datasets, offering rapid access to deep clinical data, insights and outcomes in Psoriasis.
Research-Grade RWD in Psoriasis
149,000*
PsO patients with deep clinical data longitudinally followed by dermatologists with mean follow-up of 7.9 years (98% with linked EMR & claims).
*Counts complete through Q2 2024
1.5 million*
PsO patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes
A Closer Look at the PsO Network
Immunology Resources
eBook: PsO Insights
Publications
- Poster (Collaboration with Amgen): Cavanaugh C, Orroth K, Kumparatana P, Klyachkin Y, Colgan S, Deignan C, Cordey M, Mehta N; A Real World Analysis of Apremilast and Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis, Including Impact on Weight Loss by Diabetic Status. Presented at European Academy of Dermatology and Venereology, Berlin, Germany; October 11-14, 2023.
- Stevens L, Kumparatana P, Elyze M, Clemens R, Weiss S. Characterization of Patients with Co-morbid Dermatological and Mental Health Conditions. AAD Annual Meeting, March 2023, New Orleans LA.
